Peptide Therapeutics Market Growth Opportunity 2021 to 2027

    Peptide Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Generic and Innovative), Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, and Others), Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), and Application (Cancer, Cardiovascular Disorder, Metabolic Disorder, Respiratory Disorder, Pain, and Dermatology), and Geography

    Publication Month: Feb 2021 | Report Code: TIPRE00003793 | No. of Pages: 198 | Category: Biotechnology | Status: Published

    The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% from 2020 to 2027.

    Peptides are naturally occurring biological molecules that play a prominent role in important biological activities. Extensive efforts have been taken in pharmaceutical research and development (R&D) to develop new peptides for the treatment of chronic conditions. Over 7000 naturally occurring peptides have been identified in recent years, which function as neurotransmitters, hormones, ion channel ligands, and growth factors, amongst others to facilitate various human physiologies. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptide therapeutics market growth.

    Increasing utilization of peptide molecules for the development of COVID-19 vaccine is estimated to have a positive impact on the market growth. Moreover, extensive support from government authorities for the use of peptides for COVID-19 vaccine development is also anticipated to offer potential opportunity for the adoption of peptides, which will eventually accelerate the growth of peptide therapeutics market.

    Lucrative Regions for Peptide Therapeutics Market

    Lucrative Regions for Peptide Therapeutics Market

    Get more information on this report :



    Market Insights


    Increasing Prevalence of Metabolic Disorders and Infectious Diseases Drives Peptide Therapeutics Market Growth

    Increasing prevalence of metabolic and infectious diseases is one of the prominent factors expected to drive the peptide therapeutics market. For instance, according to a data published by the Centers of Disease Control and Prevention (CDC) in 2020, an estimated 34.2 million people in the US were suffering from diabetes. In addition, according to the same studies, the prevalence of diabetes is continually increasing as compared to the past decades. In addition, according to a study published by the CDC in 2020, approximately 400 babies are diagnosed with hemophilia each year in the US. Further, according to a study published by the NIH in 2019, sickle cell anemia affects around 100,000 people in the US and one million people across the globe each year. Further, according to a study conducted by the International Agency for Research on Cancer in 2020, around 19.3 million people worldwide were suffering from cancer. Also, according to the same study, cancer was responsible for around 10 million deaths globally. Besides, according to a data published by the World Health Organization in 2020, cardiovascular diseases are responsible for deaths of around 17.9 million worldwide each year. The applicability of peptide therapies for treatment of viral infections and chronic diseases, such as neurological diseases, cancer, and diabetes, is projected to drive the adoption of peptide therapies as one of the prominent treatment alternatives. This, in turn, would boost the growth of the peptide therapeutics market during the forecast period. For instance, in October 2020, CohBar, Inc., a clinical stage biotechnology company, announced positive results of its study for CB5138 peptide and Nintedanib. The company is evaluating efficacy of CB5138 peptide and Nintedanib combination for the treatment of idiopathic pulmonary fibrosis.

    Type-Based Insights

    Based on type, the peptide therapeutics market is segmented into innovative and generics. The innovative segment held a larger share of the market in 2019; however, the generics segment is estimated to register a higher CAGR during the forecast period.

    Peptide Therapeutics Market, by Type – 2019 and 2027

    Peptide Therapeutics Market, by Type – 2019 and 2027

    Get more information on this report :



    Route of Administration-Based Insights

    Based on route of administration, the peptide therapeutics market is segmented into parenteral, mucosal, oral, pulmonary, and others. The parenteral segment held the largest share of the market in 2019; however, the oral segment is estimated to register the highest CAGR during the forecast period.

    Synthesis Technology-Based Insights

    Based on synthesis technology, the peptide therapeutics market is segmented into solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and hybrid technology. The solid phase peptide synthesis (SPPS) segment held the largest share of the market in 2019; however, hybrid technology segment is estimated to register the highest CAGR during the forecast period.

    Application-Based Insights

    Based on application, the peptide therapeutics market is segmented into cancer, metabolic disorder, cardiovascular disorder, respiratory disorder, pain, and dermatology. The cancer segment held the largest share of the market in 2019; however, metabolic disorders segment is estimated to register the highest CAGR during the forecast period.

    Strategic Insights

    The peptide therapeutics market players have been prominently adopting the product innovation strategy to cater to changing customer demands worldwide, which also enables them to maintain their brand name in the global market.

    Peptide Therapeutics Market – by Type

    • Innovative
    • Generic


    Peptide Therapeutics Market – by Route of Administration

    • Parenteral
    • Mucosal
    • Oral
    • Pulmonary
    • Others


    Peptide Therapeutics Market – by Synthesis Technology

    • Solid Phase Peptide Synthesis (SPPS)
    • Liquid Phase Peptide Synthesis (LPPS)
    • Hybrid Technology


    Peptide Therapeutics Market – by Application

    • Cancer
    • Metabolic Disorder
    • Cardiovascular Disorder
    • Respiratory Disorder
    • Pain
    • Dermatology

    Peptide Therapeutics Market – by Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific(APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East and Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • Eli Lilly and Company
    • Amgen Inc.
    • TEVA PHARMACEUTICAL INDUSTRIES LTD
    • Polypeptide Group
    • EVER Pharma GmbH
    • Bristol-Myers Squibb Company
    • Novo Nordisk A/S
    • Sanofi
    • AstraZeneca PLC
    • Glaxosmithkline PLC

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Peptide Therapeutics Market – By Type

    1.3.2 Global Peptide Therapeutics Market – By Route of Administration

    1.3.3 Global Peptide Therapeutics Market – By Synthesis Technology

    1.3.4 Global Peptide Therapeutics Market – By Application

    1.3.5 Global Peptide Therapeutics Market – By Geography

    2. Peptide Therapeutics Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Peptide Therapeutics – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa (MEA) – PEST Analysis

    4.2.5 South and Central America (SCAM) – PEST Analysis

    4.3 Expert Opinion

    5. Peptide Therapeutics Market – Key Market Dynamics

    5.1 Market Drivers

    5.1.1 Growing Investments on Peptide Therapeutics

    5.1.2 Increasing Prevalence of Metabolic Disorders and Infectious Diseases

    5.2 Market Restraints

    5.2.1 Operational Limitations of Peptides

    5.3 Market Opportunities

    5.3.1 Strong Pipeline and Applications of Peptide Drugs

    5.4 Future Trends

    5.4.1 Emphasis on Automatic Peptide Synthesis

    5.5 Impact Analysis

    6. Peptide Therapeutics Market – Global Analysis

    6.1 Global Peptide Therapeutics Market Revenue Forecast And Analysis

    6.2 Global Peptide Therapeutics Market, By Geography - Forecast And Analysis

    6.3 Market Positioning of Key Players

    7. Peptide Therapeutics Market Analysis – By Type

    7.1 Overview

    7.2 Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)

    7.3 Generic

    7.3.1 Overview

    7.3.2 Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    7.4 Innovative

    7.4.1 Overview

    7.4.2 Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    8. Peptide Therapeutics Market Analysis – By Route of Administration

    8.1 Overview

    8.2 Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

    8.3 Parenteral

    8.3.1 Overview

    8.3.2 Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    8.4 Oral

    8.4.1 Overview

    8.4.2 Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    8.5 Mucosal

    8.5.1 Overview

    8.5.2 Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    8.6 Pulmonary

    8.6.1 Overview

    8.6.2 Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    8.7 Others

    8.7.1 Overview

    8.7.2 Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    9. Peptide Therapeutics Market Analysis – By Synthesis Technology

    9.1 Overview

    9.2 Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)

    9.3 Solid Phase Peptide Synthesis (SPPS)

    9.3.1 Overview

    9.3.2 Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    9.4 Liquid Phase Peptide Synthesis (LPPS)

    9.4.1 Overview

    9.4.2 Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    9.5 Hybrid Technology

    9.5.1 Overview

    9.5.2 Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    10. Peptide Therapeutics Market– Application

    10.1 Overview

    10.2 Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)

    10.3 Cancer

    10.3.1 Overview

    10.3.2 Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    10.4 Cardiovascular Disorders

    10.4.1 Overview

    10.4.2 Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    10.5 Metabolic Disorder

    10.5.1 Overview

    10.5.2 Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    10.6 Respiratory Disorders

    10.6.1 Overview

    10.6.2 Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    10.7 Pain

    10.7.1 Overview

    10.7.2 Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    10.8 Dermatology

    10.8.1 Overview

    10.8.2 Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    11. Peptide Therapeutics Market – Geographic Analysis

    11.1 North America: Peptide Therapeutics Market

    11.1.1 Overview

    11.1.2 North America: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.1.3 North America: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.1.4 North America: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.1.5 North America: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.1.6 North America: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.1.7 North America: Peptide Therapeutics Market, by Country, 2019& 2027 (%)

    11.1.8 US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.1.8.1 US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.1.8.2 US: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.1.8.3 US: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.1.8.4 US: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.1.8.5 US: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.1.9 Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.1.9.1 Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.1.9.2 Canada: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.1.9.3 Canada: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.1.9.4 Canada: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.1.9.5 Canada: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.1.10 Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.1.10.1 Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.1.10.2 Mexico: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.1.10.3 Mexico: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.1.10.4 Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.1.10.5 Mexico: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.2 Europe: Peptide Therapeutics Market

    11.2.1 Overview

    11.2.2 Europe: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)

    11.2.3 Europe: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.2.4 Europe: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.2.5 Europe: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.2.6 Europe: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.2.7 Europe: Peptide Therapeutics Market, by Country, 2019& 2027 (%)

    11.2.8 Germany: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.8.1 Germany: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.8.2 Germany: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.2.8.3 Germany: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.2.8.4 Germany: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.2.8.5 Germany: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.2.9 UK: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.9.1 UK: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.9.2 UK: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.2.9.3 UK: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.2.9.4 UK: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.2.9.5 UK: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.2.10 France: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.10.1 France: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.10.2 France: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.2.10.3 France: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.2.10.4 France: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.2.10.5 France: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.2.11 Spain: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.11.1 Spain: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.11.2 Spain: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.2.11.3 Spain: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.2.11.4 Spain: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.2.11.5 Spain: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.2.12 Italy: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.12.1 Italy: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.12.2 Italy: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.2.12.3 Italy: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.2.12.4 Italy: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.2.12.5 Italy: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.2.13 Rest of Europe: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.13.1 Rest of Europe: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.2.13.2 Rest of Europe: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.2.13.3 Rest of Europe: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.2.13.4 Rest of Europe: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.2.13.5 Rest of Europe: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.3 Asia Pacific: Peptide Therapeutics Market

    11.3.1 Overview

    11.3.2 Asia Pacific: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)

    11.3.3 Asia Pacific: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.3.4 Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.3.5 Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.3.6 Asia Pacific: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.3.7 Asia Pacific: Peptide Therapeutics Market, by Country, 2019& 2027 (%)

    11.3.8 China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.8.1 China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.8.2 China: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.3.8.3 China: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.3.8.4 China: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.3.8.5 China: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.3.9 Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.9.1 Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.9.2 Japan: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.3.9.3 Japan: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.3.9.4 Japan: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.3.9.5 Japan: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.3.10 India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.10.1 India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.10.2 India: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.3.10.3 India: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.3.10.4 India: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.3.10.5 India: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.3.11 South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.11.1 South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.11.2 South Korea: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.3.11.3 South Korea: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.3.11.4 South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.3.11.5 South Korea: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.3.12 Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.12.1 Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.3.12.2 Australia: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.3.12.3 Australia: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.3.12.4 Australia: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.3.12.5 Australia: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.3.13 Rest of Asia Pacific: Peptide Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

    11.3.13.1 Rest of Asia Pacific: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)

    11.3.13.2 Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.3.13.3 Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.3.13.4 Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.3.13.5 Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.4 Middle East & Africa: Peptide Therapeutics Market

    11.4.1 Overview

    11.4.2 Middle East & Africa: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)

    11.4.3 Middle East and Africa: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.4.4 Middle East and Africa: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.4.5 Middle East and Africa: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.4.6 Middle East and Africa: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.4.7 Middle East & Africa: Peptide Therapeutics Market Share by Country – 2019 & 2027, (%)

    11.4.8 Saudi Arabia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.4.8.1 Saudi Arabia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.4.8.2 Saudi Arabia: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.4.8.3 Saudi Arabia: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.4.8.4 Saudi Arabia: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.4.8.5 Saudi Arabia: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.4.9 UAE: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.4.9.1 UAE: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.4.9.2 UAE: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.4.9.3 UAE: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.4.9.4 UAE: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.4.9.5 UAE: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.4.10 South Africa: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    11.4.10.1 South Africa: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.4.10.2 South Africa: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.4.10.3 South Africa: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.4.10.4 South Africa: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.4.10.5 South Africa: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.4.11 Rest of Middle East and Africa: Peptide Therapeutics Market - Revenue and Forecasts to 2027 (USD Million)

    11.4.11.1 Rest of Middle East and Africa: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)

    11.4.11.2 Rest of Middle East and Africa: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.4.11.3 Rest of Middle East and Africa: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.4.11.4 Rest of Middle East and Africa: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.4.11.5 Rest of Middle East and Africa: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.5 South and Central America: Peptide Therapeutics Market

    11.5.1 Overview

    11.5.2 South and Central America: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)

    11.5.3 South and Central America: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.5.4 South and Central America: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.5.5 South and Central America: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.5.6 South and Central America: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.5.7 South and Central America: Peptide Therapeutics Market, by Country, 2019 & 2027 (%)

    11.5.8 Brazil: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.5.8.1 Brazil: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.5.8.2 Brazil: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.5.8.3 Brazil: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.5.8.4 Brazil: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.5.8.5 Brazil: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.5.9 Argentina: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.5.9.1 Argentina: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    11.5.9.2 Argentina: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.5.9.3 Argentina: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.5.9.4 Argentina: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.5.9.5 Argentina: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    11.5.10 Rest of South and Central America: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)

    11.5.10.1 Rest of South and Central America: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)

    11.5.10.2 Rest of South and Central America: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

    11.5.10.3 Rest of South and Central America: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

    11.5.10.4 Rest of South and Central America: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

    11.5.10.5 Rest of South and Central America: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

    12. Impact of COVID-19 Pandemic on Global Peptide Therapeutics Market

    12.1 North America: Impact Assessment of COVID-19 Pandemic

    12.2 Europe: Impact Assessment of COVID-19 Pandemic

    12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    12.5 South and Central America: Impact Assessment of COVID-19 Pandemic

    13. Peptide Therapeutics Market– Industry Landscape

    13.1 Overview

    13.1 Growth Strategies Done by the Companies in the Market, (%)

    13.2 Organic Developments

    13.2.1 Overview

    13.3 Inorganic Developments

    13.3.1 Overview

    14. Company Profiles

    14.1 Amgen Inc.

    14.1.1 Key Facts

    14.1.2 Business Description

    14.1.3 Products and Services

    14.1.4 Financial Overview

    14.1.5 SWOT Analysis

    14.1.6 Key Developments

    14.2 Eli Lilly and Company

    14.2.1 Key Facts

    14.2.2 Business Description

    14.2.3 Products and Services

    14.2.4 Financial Overview

    14.2.5 SWOT Analysis

    14.2.6 Key Developments

    14.3 EVER Pharma GmbH

    14.3.1 Key Facts

    14.3.2 Business Description

    14.3.3 Products and Services

    14.3.4 Financial Overview

    14.3.5 SWOT Analysis

    14.3.6 Key Developments

    14.4 Polypeptide Group

    14.4.1 Key Facts

    14.4.2 Business Description

    14.4.3 Products and Services

    14.4.4 Financial Overview

    14.4.5 SWOT Analysis

    14.4.6 Key Developments

    14.5 TEVA PHARMACEUTICAL INDUSTRIES LTD

    14.5.1 Key Facts

    14.5.2 Business Description

    14.5.3 Products and Services

    14.5.4 Financial Overview

    14.5.5 SWOT Analysis

    14.5.6 Key Developments

    14.6 AstraZeneca

    14.6.1 Key Facts

    14.6.2 Business Description

    14.6.3 Products and Services

    14.6.4 Financial Overview

    14.6.5 SWOT Analysis

    14.6.6 Key Developments

    14.7 Bristol-Myers Squibb Company

    14.7.1 Key Facts

    14.7.2 Business Description

    14.7.3 Products and Services

    14.7.4 Financial Overview

    14.7.5 SWOT Analysis

    14.7.6 Key Developments

    14.8 GlaxoSmithKline plc.

    14.8.1 Key Facts

    14.8.2 Business Description

    14.8.3 Products and Services

    14.8.4 Financial Overview

    14.8.5 SWOT Analysis

    14.8.6 Key Developments

    14.9 Novo Nordisk A/S

    14.9.1 Key Facts

    14.9.2 Business Description

    14.9.3 Products and Services

    14.9.4 Financial Overview

    14.9.5 SWOT Analysis

    14.9.6 Key Developments

    14.10 Sanofi

    14.10.1 Key Facts

    14.10.2 Business Description

    14.10.3 Products and Services

    14.10.4 Financial Overview

    14.10.5 SWOT Analysis

    14.10.6 Key Developments

    15. Appendix

    15.1 About The Insight Partners

    15.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 2. North America Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 3. North America Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 4. North America Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 5. US Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 6. US Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 7. US Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 8. US Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 9. Canada Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 10. Canada Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 11. Canada Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 12. Canada Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 13. Mexico Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 14. Mexico Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 15. Mexico Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 16. Mexico Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 17. Europe Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 18. Europe Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 19. Europe Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 20. Europe Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 21. Germany Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 22. Germany Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 23. Germany Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 24. Germany Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 25. UK Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 26. UK Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 27. UK Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 28. UK Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 29. France Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 30. France Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 31. France Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 32. France Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 33. Spain Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 34. Spain Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 35. Spain Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 36. Spain Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 37. Italy Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 38. Italy Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 39. Italy Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 40. Italy Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 41. Rest of Europe Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 42. Rest of Europe Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 43. Rest of Europe Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 44. Rest of Europe Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 45. Asia Pacific Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 46. Asia Pacific Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 47. Asia Pacific Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 48. Asia Pacific Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 49. China Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 50. China Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 51. China Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 52. China Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 53. Japan Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 54. Japan Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 55. Japan Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 56. Japan Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 57. India Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 58. India Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 59. India Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 60. India Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 61. South Korea Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 62. South Korea Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 63. South Korea Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 64. South Korea Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 65. Australia Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 66. Australia Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 67. Australia Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 68. Australia Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 69. Rest of Asia Pacific Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 70. Rest of Asia Pacific Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 71. Rest of Asia Pacific Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 72. Rest of Asia Pacific Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 73. Middle East and Africa Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 74. Middle East and Africa Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 75. Middle East and Africa Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 76. Middle East and Africa Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 77. Saudi Arabia Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 78. Saudi Arabia Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 79. Saudi Arabia Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 80. Saudi Arabia Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 81. UAE Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 82. UAE Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 83. UAE Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 84. UAE Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 85. South Africa Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 86. South Africa Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 87. South Africa Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 88. South Africa Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 89. Rest of Middle East and Africa Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 90. Rest of Middle East and Africa Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 91. Rest of Middle East and Africa Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 92. Rest of Middle East and Africa Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 93. South and Central America Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 94. South and Central America Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 95. South and Central America Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 96. South and Central America Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 97. Brazil Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 98. Brazil Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 99. Brazil Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 100. Brazil Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 101. Argentina Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 102. Argentina Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 103. Argentina Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 104. Argentina Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 105. Rest of South and Central America Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 106. Rest of South and Central America Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 107. Rest of South and Central America Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

    Table 108. Rest of South and Central America Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 109. Organic Developments Done by Companies

    Table 110. Inorganic Developments Done by Companies

    Table 111. Glossary of Terms, Peptide Therapeutics Market

    LIST OF FIGURES

    Figure 1. Peptide Therapeutics Market Segmentation

    Figure 2. Peptide Therapeutics Market Segmentation, By Region

    Figure 3. Global Peptide Therapeutics Market Overview

    Figure 4. Innovative Segment Held Largest Share of Peptide Therapeutics Market

    Figure 5. APAC to Show Significant Growth During Forecast Period

    Figure 6. Peptide Therapeutics Market, by Geography (US$ Million)

    Figure 7. Global Peptide Therapeutics Market – Leading Country Markets (US$ Million)

    Figure 8. Global Peptide Therapeutics Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East & Africa PEST Analysis

    Figure 13. South and Central America (SCAM) PEST Analysis

    Figure 14. Peptide Therapeutics Market Impact Analysis of Drivers and Restraints

    Figure 15. Global Peptide Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027

    Figure 16. Global Peptide Therapeutics Market – By Geography Forecast and Analysis – 2019- 2027

    Figure 17. Market Positioning of Key Players in Global Peptide Therapeutics Market

    Figure 18. Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)

    Figure 19. Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 20. Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 21. Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

    Figure 22. Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 23. Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 24. Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 25. Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 26. Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 27. Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)

    Figure 28. Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 29. Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 30. Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 31. Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)

    Figure 32. Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    Figure 33. Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    Figure 34. Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    Figure 35. Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    Figure 36. Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    Figure 37. Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

    Figure 38. North America: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

    Figure 39. North America Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)

    Figure 40. North America: Peptide Therapeutics Market, by Country, 2019 & 2027 (%)

    Figure 41. US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 42. Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 43. Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 44. Europe: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

    Figure 45. Europe Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)

    Figure 46. Europe: Peptide Therapeutics Market, by Country, 2019& 2027 (%)

    Figure 47. Germany: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 48. UK: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 49. France: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 50. Spain: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 51. Italy: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 52. Rest of Europe: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 53. Asia Pacific: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

    Figure 54. Asia Pacific Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)

    Figure 55. China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 56. Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 57. India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 58. South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 59. Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 60. Rest of Asia Pacific: Peptide Therapeutics Market- Revenue And Forecasts To 2027 (USD Million)

    Figure 61. Middle East & Africa: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

    Figure 62. Middle East & Africa Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)

    Figure 63. Middle East & Africa: Peptide Therapeutics Market Share by Country – 2019 & 2027, (%)

    Figure 64. Saudi Arabia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 65. UAE: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 66. South Africa: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 67. Rest of Middle East and Africa: Peptide Therapeutics Market- Revenue And Forecasts To 2027 (USD Million)

    Figure 68. South and Central America: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

    Figure 69. South and Central America Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)

    Figure 70. South and Central America: Peptide Therapeutics Market, by Country, 2019 & 2027 (%)

    Figure 71. Brazil: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 72. Argentina: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

    Figure 73. Rest of South and Central America: Peptide Therapeutics Market- Revenue And Forecasts To 2027 (USD Million)

    Figure 74. Impact of COVID-19 Pandemic in North America Country Markets

    Figure 75. Impact of COVID-19 Pandemic in European Country Markets

    Figure 76. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

    Figure 77. Impact of COVID-19 Pandemic in Middle East and Africa Market

    Figure 78. Impact of COVID-19 Pandemic in South and Central America Market

    Figure 79. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - Peptide Therapeutics Market

    1. Eli Lilly and Company
    2. Amgen Inc.
    3. TEVA PHARMACEUTICAL INDUSTRIES LTD
    4. Polypeptide Group
    5. EVER Pharma GmbH
    6. Bristol-Myers Squibb Company
    7. Novo Nordisk A/S
    8. Sanofi
    9. AstraZeneca PLC
    10. Glaxosmithkline PLC  
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Peptide therapeutics market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global Peptide therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPRE00003793
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    Peptides are naturally occurring biological molecules that play a prominent role in important biological activities. There are extensive efforts have been taken in pharmaceutical research and development (R&D) to innovate new peptides for the treatment of chronic conditions. Over 7000 naturally occurring peptides have been identified in recent years, which have crucial roles in human physiology, including actions as neurotransmitters, hormones, ion channel ligands, and growth factors, amongst others.
    The growth of the market is attributed to some key driving factors such as growing investments on peptide therapeutics and increasing prevalence of metabolic and infectious diseases.
    The peptide therapeutics market majorly consists of the players such as Eli Lilly and Company, Amgen Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Polypeptide Group, EVER Pharma GmbH, Bristol-Myers Squibb Company, Novo Nordisk A/S, Sanofi, AstraZeneca PLC, and Glaxosmithkline PLC amongst others.

    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst